CC BY-NC-ND 4.0 · Indian J Plast Surg 2007; 40(02): 209-212
DOI: 10.1055/s-0039-1699206
Case Report
Association of Plastic Surgeons of India

Squamous cell carcinoma of lower lip in very young brothers of xeroderma pigmentosa

A Hemant Saraiya
Sushrut Plastic Surgery Research Center, Apollo Hospital, Ahmedabad
,
Mukul Trivedi
Sushrut Plastic Surgery Research Center, Apollo Hospital, Ahmedabad
,
Jayesh Patel
Sushrut Plastic Surgery Research Center, Apollo Hospital, Ahmedabad
,
J T Jhala
Sushrut Plastic Surgery Research Center, Apollo Hospital, Ahmedabad
› Author Affiliations
Further Information

Publication History

Publication Date:
15 January 2020 (online)

ABSTRACT

a nine-year-old xeroderma pigmentosa (xp) child presented with a non-healing ulcer on the right side of the lower lip. on histological examination the lesion proved to be squamous cell carcinoma. wide excision was done. the excision included lip, buccal mucosa with mucocutaneous junction and only the upper portion of the orbicularis oris muscle. the lip was reconstructed with superiorly based nasolabial flap. recently, his younger brother, who is also suffering from xp developed squamous cell carcinoma of lower lip, and presented to us. wide excision of the lesion was done. the defect was closed primarily. the patient and his brother both have been advised to protect themselves from uv radiation. both are being kept under intense surveillance. ten months of follow-up of the elder brother showed satisfactory, good-looking lip with no sign of recurrence at the local site or at the neck.

 
  • 1 Bhutto AM, Shaikh A, Nonaka S. Incidence of xeroderma pigmentosum in Larkana, Pakistan: A 7-year study. Br J Dermatol 2005; 152: 545-51
  • 2 Harper JI. Genetics and genodermatoses. In Champion RH, Burton JL, Burns DA, Breathnach SM. The textbook of dermatology. 6th ed. Blackwell Science CD Rom; New York: 1999. Chapter 12
  • 3 Jackson IT. Local flaps in head and neck reconstruction. 1st ed. Mosby; St. Louis: 1985. Chapter 8
  • 4 Moretti A, Zingariello P, Chiri ZM, DߣAgostino L, Croce A. Surgical treatment of malignant lip tumors: Personal experience. G Chir 2003; 24: 341-6
  • 5 Berth-Jones J, Graham-Brown RA. Xeroderma pigmentosum variant: Response to etretinate. Br J Dermatol 1990; 122: 559-61
  • 6 Kraemer KH, DiGiovanna JJ, Moshell AN, Tarone RE, Peck GL. Prevention of skin cancer in xeroderma pigmentosum with the use of oral isotretinoin. N Engl J Med 1988; 318: 1633-7
  • 7 Verret JL, Schnitzler L, Avenel M. et al. Etretinate and skin cancer prevention: A 6.5 year follow-up study. In Saurat J. editor Retinoids: New Trends in Research and Therapy. Basel: Karger; 1985: p.355-9
  • 8 Sauder DN. Editorial. J Cutan Med Surg 2000; 4: 1
  • 9 Nelson BR, Fader DJ, Gillard M, Baker SR, Johnson TM. The role of dermabrasion and chemical peels in the treatment of patients with xeroderma pigmentosum. J Am Acad Dermatol 1995; 32: 623-6
  • 10 Gleason MC. Xeroderma pigmentosum-five-year arrest after total resurfacing of the face. Plast Reconstr Surg 1970; 46: 577-81
  • 11 English JS, Swerdlow AJ. The risk of malignant melanoma, internal malignancy and mortality in xeroderma pigmentosum patients. Br J Dermatol 1987; 117: 457-61
  • 12 Mehta C, Gupta CN, Krishnaswamy M. Malignant melanoma of conjunctiva with xeroderma pigmentosa: A case report. Indian J Ophthalmol 1996; 44: 165-6
  • 13 Goyal JL, Rao VA, Srinivasan R, Agrawal K. Oculocutaneous manifestations in xeroderma pigmentosa. Br J Ophthalmol 1994; 78: 295-7
  • 14 Hertle RW, Durso F, Metzler JP, Varsa EW. Epibulbar squamous cell carcinomas in brothers with Xeroderma pigmentosa. J Pediatr Ophthalmol Strabismus 1991; 28: 350-3